Drug Profile
HS 731
Alternative Names: AS 006; HS-731Latest Information Update: 28 Jun 2022
Price :
$50
*
At a glance
- Originator AlcaSynn Pharmaceuticals
- Developer ChironWells
- Class Morphinans; Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for preclinical development in Pain in Austria (Parenteral)
- 28 Jun 2022 No recent reports of development identified for preclinical development in Pain in Austria (PO)
- 28 May 2018 Preclinical development in Pain is ongoing in Austria (PO, Parenteral) (ChironWells pipeline, May 2018)